As BRCA1/BRCA2 proteins are responsible for the repair of double-strand DNA breaks (DSBs), the presence of pathogenic variants in BRCA2 leads to the impaired activity of its protein product and thus increases the risk of a DSB in a tumor cell. The gene discussed is BRCA2; the disease is neoplasm.